AZ7976, identified by its CAS number 2813866-27-0, is a chemical compound that has garnered attention in pharmaceutical research, particularly in the context of its potential therapeutic applications. While specific characteristics such as molecular weight, structure, and solubility may vary, compounds like AZ7976 are typically characterized by their unique molecular frameworks that influence their biological activity. AZ7976 is often studied for its role in modulating specific biological pathways, which may include interactions with receptors or enzymes relevant to disease mechanisms. The compound's efficacy, safety profile, and pharmacokinetics are critical areas of investigation in preclinical and clinical studies. As with many investigational drugs, detailed information regarding its characteristics, including stability, reactivity, and potential side effects, is usually disclosed in scientific literature and regulatory submissions as research progresses. Overall, AZ7976 represents a promising candidate in the ongoing search for effective treatments in various medical conditions.

AZ7976

2813866-27-0: AZ7976, identified by its CAS number 2813866-27-0, is a chemical compound that has garnered attention in pharmaceutical research, particularly in the context of its potential therapeutic applications. While specific characteristics such as molecular weight, structure, and solubility may vary, compounds like AZ7976 are typically characterized by their unique molecular frameworks that influence their biological activity. AZ7976 is often studied for its role in modulating specific biological pathways, which may include interactions with receptors or enzymes relevant to disease mechanisms. The compound's efficacy, safety profile, and pharmacokinetics are critical areas of investigation in preclinical and clinical studies. As with many investigational drugs, detailed information regarding its characteristics, including stability, reactivity, and potential side effects, is usually disclosed in scientific literature and regulatory submissions as research progresses. Overall, AZ7976 represents a promising candidate in the ongoing search for effective treatments in various medical conditions.

<p>AZ7976 (Compound 42), a potent and highly selective agonist for Relaxin Family Peptide Receptor 1 (RXFP1) with a pEC 50 value greater than 10.5, operates through an allosteric mechanism to enhance RXFP1's cAMP signaling, which physiologically elevates heart rate. This property makes AZ7976 a valuable tool in cardiovascular disease research [1].</p>

CAS 2813866-27-0

AZ7976

AZ7976

Ref: TM-T85783